Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Alzheimer's
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Alzheimer's
    Hypertension, Markers of Inflammation In the Blood More Common in Offspring of Parents With AD - (DGNews)
    TopAbstracts in Alzheimer's 10/29/2009 - (DGNews)
    Diabetes Does Not Increase Rate of Cognitive Decline in Patients With AD - (DGNews)
    Half of Patients With Alzheimer's Disease Adhere to Cholinesterase Inhibitors After 1 Year: Presented at ANA - (DGDispatch)
    TopAbstracts in Alzheimer's 10/15/2009 - (DGNews)

    News archive

     Recent webcasts/CME - Alzheimer's
    The Dementia Caregiver-A Primary Care Approach
    Medical Care of the Patient with Dementia

    Webcasts/CME archive

     Recent cases - Alzheimer's
      Rapid Cognitive Improvement in Alzheimer's Disease Following Perispinal Etanercept Administration
      Advances in the Pharmacotherapy of Alzheimer's Disease
      Does He Have Alzheimer's Disease?

      Cases archive
        




      my personal edition > alzheimer's > news
      divider

        E-Mail this DGReview to a colleague

      DGReview


      Rivastigmine Improves Cholinergic Activity in Alzheimer's Disease

      A DGReview of :"Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease."
      Journal of Neurology, Neurosurgery, & Psychiatry (JNNP Online)

      11/29/2002
      By Veronica Rose


      Dutch researchers have found brain activation in the fusiform and frontal cortices is enhanced by rivastigmine among some patients with mild Alzheimer's disease.

      Previous clinical trial have shown that rivastigmine enhances cholinergic activity, and decrease the rate of deterioration in Alzheimer's disease. However, uncertainty remains about the part of the brain in which the effects are exerted.

      Neurologists at Vrije Universiteit Medical Centre and Department of Radiology, Amsterdam, The Netherlands, used functional magnetic resonance imaging (fMRI) to determine the location of brain changes, and then relate these changes to cognition among the patients.

      Twelve patients with mild Alzheimer's disease were enrolled in the study. Seven of the patients received a single dose of rivastigmine before undergoing fMRI during face decoding to test its effect on brain activation. Five other patients underwent the same procedure during a parametric working memory task.

      Researchers found that rivastigmine increased bilateral activation in the fusiform gyrus during face decoding. In addition, enhanced brain activation was shown in the prefrontal cortex during a simple working memory task. A further increase in working memory load increased activation, but in certain areas there also was decreased activation.

      They said their findings link previous research "which had shown an increase in cognitive performance in patients with mild Alzheimer's disease following treatment with a cholinesterase inhibitor" to altered brain activity.

      "Although the results cannot be generalised to the Alzheimer's disease population at large, they provide evidence that in mild Alzheimer's disease, rivastigmine enhances brain activation in the fusiform and frontal cortices," they conclude. "This is compatible with the concept of cholinergic circuitry."
      Journal of Neurology Neurosurgical Psychiatry Dec 2002; Vol.73: No.6: pp 665-71. "Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease."

      E-Mail this DGReview to a colleague   To print, use this version






      All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send